相关实验视频

Updated: Jul 7, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

对于卵巢癌的CAR-T细胞免疫疗法:让无声的杀手沉默

Fatemeh Nasiri^1,2, Khadijeh Farrokhi³, Pouya Safarzadeh Kozani¹

¹Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Frontiers in immunology

|December 26, 2023

概括

化学抗原受体T细胞 (CAR-T) 疗法对卵巢癌具有前景,但固体瘤挑战如免疫抑制和抗原向需要解决. 研究正在探索CAR-T在卵巢癌治疗中的临床前和临床发现.

科学领域:

妇科瘤学妇科瘤学
癌症免疫疗法癌症免疫疗法
细胞疗法细胞疗法

背景情况:

卵巢癌是癌症死亡的主要原因,通常是晚期诊断的,传统治疗后复发率高.
目前用于卵巢癌的免疫疗法是有限的; 化学抗原受体T细胞 (CAR-T) 疗法在血液恶性瘤中取得了成功,但在固体瘤中面临挑战.
固体瘤中CAR-T的障碍包括免疫抑制的微环境,瘤透不良,目标抗原有限,T细胞功能受损.

研究的目的:

审查CAR-T疗法的原则.
突出CAR-T疗法的局限性在固体瘤的背景下,特别是卵巢癌.
总结关于CAR-T介导的卵巢癌抗原的临床前和临床发现.

主要方法:

关于CAR-T疗法原则和应用的现有文献的审查.
在固体瘤中分析CAR-T疗法的挑战和局限性.
关于CAR-T针对卵巢癌抗原的临床前和临床数据的汇编和讨论.

主要成果:

虽然CAR-T疗法在血液癌症中取得了成功,但在卵巢癌等固体瘤中面临重大障碍.
研究人员正在积极研究用于CAR-T向的各种卵巢癌相关抗原.
临床前和临床研究正在探索克服卵巢癌中CAR-T限制的策略.

结论:

CAR-T疗法对卵巢癌治疗有潜力,但克服固体瘤特异性挑战至关重要.
识别和向适当的瘤相关抗原是有效的CAR-T治疗卵巢癌的关键.
对临床前和临床应用的持续研究是必要的,以推进卵巢癌患者的CAR-T疗法.

关键词:

采用细胞疗法采用细胞疗法癌症免疫疗法免疫疗法仿制性抗原受体的复制性受体.卵巢癌是发生在卵巢的癌症.固体瘤是一种固体瘤.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...